Friday, October 22nd, 2021

A little ‘skinsight’ into a very clever organ

Skin is famously the largest organ on your body. In fact, the average person’s skin covers about two square metres and equates to about 15% of your body weight. So it’s pretty significant. And although

Thursday, October 14th, 2021

Conference report: European Academy of Dermatology and Venereology annual congress

Alison BloomerGM, 04 October 2021 The European Academy of Dermatology and Venereology (EADV) annual congress took place virtually between September 29-October 2. It presented new findings and scientific breakthroughs and in the field of dermatology

Tuesday, October 5th, 2021

“Winter is Coming” – Protect your Skin!

The September sun was a welcome relief after a less than satisfactory summer during the earlier months. But the drop in temperature in the last few days means that in the words of House Stark,

Thursday, September 30th, 2021

Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

“Topical therapy has always been a keystone of therapy for patients with more limited psoriasis,” April W. Armstrong, professor of dermatology and associate dean at Keck School of Medicine at USC, told Healio. To address

Friday, August 20th, 2021

Topical proteasome inhibitor promising for rosacea treatment

Topical ACU-D1 was safe, well tolerated and efficacious in treating rosacea, according to a phase 2a study published in the Journal of Drugs in Dermatology. ACU-D1 (pentaerythritol tetrakis (3-(3, 5-di-tert-butyl-4-hydroxyphenyl) propionate), a novel topical proteasome

Tuesday, August 17th, 2021

Study examines risk factors for systemic lupus erythematosus development.

Among patients with lupus erythematosus panniculitis resulting from cutaneous lupus erythematosus, male sex anddiscoid lupus erythematosus were risk factors for systemic lupus erythematosus development, according to a study. “Lupus erythematosus panniculitis (LEP) occurs in 1% to

Tuesday, August 17th, 2021

Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis

Photodynamic therapy with aminolevulinate and imiquimod are among the treatments with good long-term efficacy for actinic keratosis, according to an investigation published in JAMA Dermatology. “Actinic keratoses (AK) are common precancerous lesions of the skin

Tuesday, August 17th, 2021

Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan

Biologic therapies demonstrated improved morbidity and mortality outcomes compared with oral agents and steroids in patients with generalized pustular psoriasis, according to a study. “Because generalized pustular psoriasis (GPP) is uncommon, there are few studies